Pieris Pharmaceuticals, Inc. (PIRS)
NASDAQ: PIRS · IEX Real-Time Price · USD
7.25
-0.40 (-5.23%)
At close: Jul 19, 2024, 12:00 AM
7.51
+0.26 (3.59%)
Pre-market: Jul 22, 2024, 9:21 AM EDT
Pieris Pharmaceuticals Employees
As of December 31, 2023, Pieris Pharmaceuticals had 50 total employees, including 46 full-time and 4 part-time employees. The number of employees decreased by 94 or -65.28% compared to the previous year.
Employees
50
Change (1Y)
-94
Growth (1Y)
-65.28%
Revenue / Employee
$818,540
Profits / Employee
-$325,040
Market Cap
9.57M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
PAVmed | 107 |
Tonix Pharmaceuticals Holding | 103 |
Plus Therapeutics | 20 |
ABVC BioPharma | 19 |
Moleculin Biotech | 18 |
Elevai Labs | 18 |
Nexalin Technology | 6 |
MIRA Pharmaceuticals | 3 |
PIRS News
- 3 months ago - Pieris Pharmaceuticals Announces 1-for-80 Reverse Stock Split - Accesswire
- 4 months ago - Pieris Pharmaceuticals Announces Strategy to Maximize Partnered Milestone and Royalty Potential - Accesswire
- 1 year ago - Pieris Pharmaceuticals Announces Milestone Achievement for Boston Pharmaceuticals' Initiation of Phase 1/2 Study of BOS-342, a 4-1BB/GPC3 Immuno-Oncology Bispecific - Accesswire
- 1 year ago - Pieris Pharmaceuticals Provides Strategic Update and Announces Restructuring - Accesswire
- 1 year ago - Pieris Pharmaceuticals Announces AstraZeneca Discontinuation of Phase 2a Trial of Elarekibep (PRS-060/AZD1402) Due to New Non-Clinical Safety Findings From 13-week Toxicology Study - Accesswire
- 1 year ago - Pieris Pharmaceuticals to Present at Jefferies 2023 Healthcare Conference - Accesswire
- 1 year ago - Pieris Pharmaceuticals Announces Presentation of Encouraging Preclinical Data for PRS-400 at ATS 2023 International Conference - Accesswire
- 1 year ago - Pieris Pharmaceuticals Announces Presentation of Promising Preclinical Data for PRS-220 at ATS 2023 International Conference - Accesswire